DrugPatentWatch Database Preview
RESTASIS MULTIDOSE Drug Profile
When do Restasis Multidose patents expire, and what generic alternatives are available?
Restasis Multidose is a drug marketed by Allergan and is included in one NDA. There are ten patents protecting this drug.
This drug has thirty-five patent family members in thirteen countries.
The generic ingredient in RESTASIS MULTIDOSE is cyclosporine. There are eighteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
Summary for RESTASIS MULTIDOSE
| International Patents: | 35 |
| US Patents: | 10 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Clinical Trials: | 40 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for RESTASIS MULTIDOSE |
| Prior Art and Litigation Support | Order Prior Art and Litigation support for RESTASIS MULTIDOSE |
| DailyMed Link: | RESTASIS MULTIDOSE at DailyMed |
Pharmacology for RESTASIS MULTIDOSE
| Drug Class | Calcineurin Inhibitor Immunosuppressant |
| Mechanism of Action | Calcineurin Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
Medical Subject Heading (MeSH) Categories for RESTASIS MULTIDOSE
US Patents and Regulatory Information for RESTASIS MULTIDOSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | RESTASIS MULTIDOSE | cyclosporine | EMULSION;OPHTHALMIC | 050790-002 | Oct 27, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Allergan | RESTASIS MULTIDOSE | cyclosporine | EMULSION;OPHTHALMIC | 050790-002 | Oct 27, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Allergan | RESTASIS MULTIDOSE | cyclosporine | EMULSION;OPHTHALMIC | 050790-002 | Oct 27, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Allergan | RESTASIS MULTIDOSE | cyclosporine | EMULSION;OPHTHALMIC | 050790-002 | Oct 27, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for RESTASIS MULTIDOSE
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2014368816 | ➤ Sign Up |
| European Patent Office | 3083432 | ➤ Sign Up |
| Japan | 5412302 | ➤ Sign Up |
| Germany | 102014201696 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
